LBL-034

· Nanjing Leads Biolabs Co.,Ltd

Drug timelines are a Plus or Pro feature.

1 regulatory and trial event tracked for LBL-034, covering 2025-12-04 to 2025-12-04. Get the full timeline:

Most recent: Clinical Trial Update: A Phase I/II Clinical Trial of LBL-034 in Patients With Relapsed Refractory Multiple Myeloma [Phase 1, Phase 2]